Definition/General
Introduction:
Blunt duct adenosis is a benign breast lesion characterized by a proliferation of small, uniform glands with open lumina, but without the stromal sclerosis or distortion of sclerosing adenosis
It is a component of fibrocystic changes.
Origin:
It arises from the terminal duct-lobular unit (TDLU).
Classification:
It is classified as a benign non-proliferative breast lesion.
Epidemiology:
It is a very common incidental finding in breast biopsies.
Clinical Features
Presentation:
It is an incidental microscopic finding.
Symptoms:
Asymptomatic.
Risk Factors:
There are no well-established risk factors.
Screening:
It does not have specific mammographic features.
Master Blunt Duct Adenosis Pathology with RxDx
Access 100+ pathology videos and expert guidance with the RxDx app
Gross Description
Appearance:
There are no specific gross findings.
Characteristics:
Gross findings are not specific for this microscopic diagnosis.
Size Location:
Gross findings are not specific for this microscopic diagnosis.
Multifocality:
Often multifocal.
Microscopic Description
Histological Features:
The lesion is composed of a proliferation of duct-like structures lined by a double layer of epithelial and myoepithelial cells
The glands are rounded and not compressed
The surrounding stroma is not sclerotic.
Cellular Characteristics:
The epithelial cells are cuboidal and bland
The myoepithelial layer is intact and often prominent.
Architectural Patterns:
The key feature is the proliferation of glands without stromal sclerosis or architectural distortion.
Grading Criteria:
This is a benign lesion.
Immunohistochemistry
Positive Markers:
The myoepithelial cell layer is highlighted by myoepithelial markers such as p63 and calponin.
Negative Markers:
Not typically required for diagnosis.
Diagnostic Utility:
IHC is not usually necessary for diagnosis.
Molecular Subtypes:
Molecular subtyping is not relevant for this benign condition.
Molecular/Genetic
Genetic Mutations:
This is a benign condition and is not associated with specific genetic mutations.
Molecular Markers:
No specific molecular markers are routinely used for diagnosis.
Prognostic Significance:
Blunt duct adenosis is not associated with an increased risk of developing invasive breast cancer.
Therapeutic Targets:
No treatment is required.
Differential Diagnosis
Similar Entities:
Sclerosing adenosis
Tubular adenosis.
Distinguishing Features:
Sclerosing adenosis has stromal sclerosis and glandular distortion
Tubular adenosis has more closely packed, uniform tubules.
Diagnostic Challenges:
The main challenge is distinguishing it from other forms of adenosis.
Rare Variants:
There are no specific rare variants.
Sample Pathology Report
Template Format
Sample Pathology Report
Complete Report: This is an example of how the final pathology report should be structured for this condition.
Specimen Information
[specimen type], measuring [size] cm in greatest dimension
Diagnosis
[diagnosis name]
Classification
Classification: [classification system] [grade/type]
Histological Features
Shows [architectural pattern] with [nuclear features] and [mitotic activity]
Size and Extent
Size: [X] cm, extent: [local/regional/metastatic]
Margins
Margins are [involved/uninvolved] with closest margin [X] mm
Lymphovascular Invasion
Lymphovascular invasion: [present/absent]
Lymph Node Status
Lymph nodes: [X] positive out of [X] examined
Special Studies
IHC: [marker]: [result]
Molecular: [test]: [result]
[other study]: [result]
Final Diagnosis
Final diagnosis: [complete diagnosis]